The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab.

Content Provider	Europe PMC
Author	Kreuzer, Karl-Anton Furman, Richard R. Stilgenbauer, Stephan Dubowy, Ronald L. Kim, Yeonhee Munugalavadla, Veerendra Lilienweiss, Esther Reinhardt, Hans Christian Cramer, Paula Eichhorst, Barbara Hillmen, Peter O’Brien, Susan M. Pettitt, Andrew R. Hallek, Michael
ISSN	08876924
Journal	Leukemia
Volume Number	34
PubMed Central reference number	PMC7214265
Issue Number	1
PubMed reference number	31427720
e-ISSN	14765551
DOI	10.1038/s41375-019-0533-6
Language	English
Publisher	Nature Publishing Group UK
Publisher Date	2019-08-19
Publisher Place	London
Access Restriction	Open
Rights License	Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2019
Subject Keyword	Cancer genetics Cytogenetics Chronic lymphocytic leukaemia
Content Type	Text
Resource Type	Article
Subject	Hematology Cancer Research Anesthesiology and Pain Medicine Oncology